Cronos Group Q1 2024 Earnings Report $12,500.00 0.00 (0.00%) As of 04/11/2025 Earnings HistoryForecast LICT EPS ResultsActual EPS-$0.01Consensus EPS -$0.01Beat/MissMet ExpectationsOne Year Ago EPS-$0.03LICT Revenue ResultsActual Revenue$25.29 millionExpected Revenue$24.30 millionBeat/MissBeat by +$990.00 thousandYoY Revenue GrowthN/ALICT Announcement DetailsQuarterQ1 2024Date5/9/2024TimeBefore Market OpensConference Call DateThursday, May 9, 2024Conference Call Time8:30AM ETUpcoming EarningsLICT's next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules. Conference Call ResourcesConference Call AudioConference Call TranscriptInterim ReportSEC FilingEarnings HistoryLICT ProfilePowered by LICT Q1 2024 Earnings Call TranscriptProvided by QuartrMay 9, 2024 ShareLink copied to clipboard.There are 6 speakers on the call. Operator00:00:00Good morning. My name is Britney Morgan, and I will be your conference operator today. I would like to welcome everyone to Cronos Group's 2024 First Quarter Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Shane Laidlaw, Investor Relations. Operator00:00:21Please go ahead. Speaker 100:00:23Thank you, Britney, and thank you for joining us today to review Cronos' 2024 Q1 financial and business performance. Today, I am joined by our Chairman, President and CEO, Mike Gorenstein and our CFO, James Holm. Cronos issued a news release announcing our financial results this morning, which is filed on our EDGAR and SEDAR profiles. This information and the prepared remarks will also be posted on our website under Investor Relations. Before I turn the call over to Mike, let me remind you that we may make forward looking statements and refer to non GAAP financial measures during this call. Speaker 100:00:53These forward looking statements are based on management's current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward looking statements. Factors that could cause actual results to differ materially from expectations are detailed in our earnings materials and our SEC filings that are available on our website, by which any forward looking statements made during this call are qualified in their entirety. Information about non GAAP financial measures, including reconciliations to U. S. GAAP can also be found in our earnings materials that are available on our website. Speaker 100:01:23Lastly, we will be making statements regarding market share information throughout this conference call. Unless otherwise stated, all market share data is provided by HiPhire. We will now make prepared remarks and then we'll move to a question and answer session. With that, I'll pass it over to Cronos' Chairman, President and CEO, Mike Gornstein. Speaker 200:01:41Thank you, Shane, and good morning, everyone. Our year is off to a strong start, marked by 30% year over year revenue growth, fueled by market share gains in Canada and a rebound in sales in Israel, gross margin improvement and operating expense reductions from fully realizing the savings we implemented in 2023 as we are well on our way to achieving incremental savings of $5,000,000 $10,000,000 in 2024. The team's consistent and relentless focus on delivering top line growth while simultaneously driving operational efficiency has positioned Cronos for success in 2024 and beyond. I want to take a moment to discuss the cannabis market and our brand possible based on price rather than building a strong connection with the targeted segment of consumers. Without building a strong connection with consumers through a targeted approach, we see many brands we share to more focused offerings. Speaker 200:02:42With spinach, we were very intentional to target specific consumer needs and believe that was instrumental to our success. This strategy drove our success in cementing Spinach as the number 2 brand in Canada. We launched Spinach in Canada at the end of 2018, and since then the team has worked hard to bring thoughtful innovations to market across different categories. I'm so proud of the team and what we've achieved. And we leveraged that success of spinach as a blueprint for our broader portfolio, starting with Lord Jones. Speaker 200:03:10We returned Lord Jones to its adult use roots and brought it to Canada to attack product categories with a more narrow premium focus where we think brand share will be stickier and borderless. Since launching with Hash and Fuse pre rolled in Q4 2023, we expanded the portfolio in Q1 to also include chocolate fusions and live resin vapes that have done well in the early days following the launch. We continue to expand the reach of our leading international brand Peace Naturals. Utilizing our best in class genetics and high quality cultivation, we have brought strains such as wedding cake and GMO cookies to Israel, Germany, Australia and now the UK. Utilizing the Peace Naturals brand in new markets we enter, we continue to cement our flower products as leaders in the market and lay the groundwork for when regulations allow us to launch borderless products such as edibles and vapes. Speaker 200:04:03Let's dive into how our brand is performing in market. Our strength of spinach extends across various product categories, notably in flower, edibles and vapes, where we are top 3 share positions. We've seen exceptional performance with our top products such as our GMO cookies flower, sours by spinach edibles and new flavor forward 1.2 gram base, driving significant market traction. In Q1, Spinach continued its strength in the dried flower category, remaining the number one brand with 6.5% of retail sales. This success is driven by years of genetic breeding, investment in R and D, including tissue culture and best in class cultivation at scale with our JV Cronos GrowCo. Speaker 200:04:49In the quarter, we launched new flower strains and formats, including ASG in 28 grams and Alien Kush in 3.5 grams, and we continue to develop new strains to bring to market, which capitalize on this lead. We also launched a new brand specifically for the Quebec market called Sonique, which will feature high quality flower products to meet consumer demand for this market. In the edibles category, spinach had 14.4% market share in Q1. Our focus on developing innovative strategies and products in this category have been instrumental in this success. The key addition to our product lineup is the fully blasted sours, a high potency 1 pack 10 milligram THC gummy, which garnered early momentum in Q1, and we are encouraged by early sales to date. Speaker 200:05:35With non compliant edibles coming off the market again and the introduction of our competitive 1 pack 10 milligram dummy, we are confident we are bringing the right products to market. Beyond our Spinach brand, we launched Lord Jones Chocolate Fusions, a bite sized chocolate featuring a dynamic multi textured experience. We believe our chocolate fusions will be a category defining product and are looking forward to getting it into more retail locations over the coming months. In the vape category, spinach maintained our number 3 market position, but gained share sequentially, now capturing 7.6% of retail sales in the category. Our new and improved spinach 1.2 gram base have received positive feedback, further solidifying our market presence and growth in this category. Speaker 200:06:22We also launched 2 new spinach all in one vapes, Pineapple Paradise and Blueberry Dynamite. Under the Lord Jones umbrella, we launched Lord Jones Live Resin Vapes in 2 different hardware options in January. The lineup features versatile sizes, including a half gram trial size in the convenience of a very sleek all in one device and a 1 gram stock up size as a 510 thread cartridge, catering to enthusiasts and those new to the category. We are focused on driving market share in the pre roll category and continue to do extensive product development and R and D work in this area. We've launched several new Flavor 4 infused pre roll offerings under the Spinach brand as well as the multi pack. Speaker 200:07:04The Spinach fully charged party pack is a combination of infused pre rolls at 40% plus THC, which includes the finest cold filtered cannabis extract and the keep coating. Our Hash and Fuse pre roll under the Lord Jones brand has become a fan favorite and my personal favorite product. Our continued focus is to be leaders in all categories we operate in and that remains a north star for our efforts in the pre roll category. Turning our attention to international markets. Our operations in Israel rebounded well from Q4, which was impacted by the war. Speaker 200:07:39And Q1 was the highest revenue quarter in Israel since Q4 of 2022. The team in Israel has done a ton of work to refine their processes and approach to the market, which has yielded both higher volumes and improved average selling prices sequentially. Our strength in Israel is also driven by our GMO and wedding cake genetics, which were developed in house and have propelled the Peace Naturals brand to be a leader in the market it enters. In April, we appointed Adam Wagner as SVP, Head of Product Israel, where he was previously the VP of Finance. Adam brings significant finance and operational experience across both public and private companies to this leadership position. Speaker 200:08:21We are already seeing a positive impact from his leadership and look forward to his leadership of the business. We are confident that our team's approach to the Israeli market is as good as ever, and I believe that with their leadership, we will continue to refine and improve over time. We're particularly excited about our growth potential in Germany, where recent legislative changes have fueled material incremental growth in the market and have allowed for opportunities to responsibly market medical cannabis products, which was not permitted under previous regulations. We are committed to delivering high quality cannabis products and nurturing our relationship with our partner, Canisotiva. We're also excited to announce another international milestone earlier this week with our first shipment to the U. Speaker 200:09:04K. Medical market. We intend to establish our Peace Naturals brand as the top medical brand for patients in the UK as we've done in Israel and Germany. International revenue can be lumpy from quarter to quarter. So although we did not have revenue in Q1 in Germany or Australia following our initial load in, we are very pleased with the end market sell through in the quarter. Speaker 200:09:27We are confident about the trajectory of our international revenue in 2024, underscoring our commitment to global expansion and revenue diversification. Our joint venture, Groco, continues to excel, demonstrating robust performance in line with our expectations. Groco reported to us preliminary unaudited revenue of approximately $5,100,000 from non Cronos customers in the Q1. Additionally, the credit facility that Cronos previously provided BroCo currently has $67,100,000 outstanding, following the principal repayments of $1,200,000 in Q1. In addition, Groco made interest payments of $1,400,000 in Q1. Speaker 200:10:08The solid financial performance of GroCo yielding equity pickup, interest payments and the loan payback to Cronos is a vital component of our overall financial picture. Turning to the U. S, last week, the media reported that the DEA plans to follow the HHS' recommendation to reschedule cannabis to Schedule 3. Proposal, which still needs to be reviewed by the White House Office of Management and Budget, would not legalize cannabis federally for adult use, but it's a dramatic shift in how the plant will be classified. We think incremental progress is great for the industry and this is a step in the right direction. Speaker 200:10:45This quarter's successes have resulted from our steadfast focus on building a portfolio of borderless products with strategic infrastructure and global partnerships. Our long term strategy to invest in branded innovation that targets specific consumer needs or remaining asset light is working and we're off to a tremendous start for our 2024 fiscal year. The combination of these efforts and an industry leading balance sheet sets us up well to grow in our current market and execute any new market we decide to enter. With that, I'd like to pass it on to James to take you through our financials. Speaker 300:11:17Thanks, Mike. Good morning, everyone. I will now review our Q1 2024 results in relation to the prior year period. The company reported consolidated net revenue of $25,300,000 a 30% increase from the prior year period. Constant currency consolidated net revenue increased by 31 percent to $25,500,000 The revenue increase was primarily driven by higher cannabis flower extract sales in Canada and higher cannabis flower sales in Israel. Speaker 300:11:45Gross profit in the Q1 was $4,500,000 equating to an 18% gross margin representing a $1,500,000 improvement in gross profit and a 2 70 basis point improvement in gross margin from the prior year The increase is primarily driven by higher sales in cannabis flower extracts in Canada and higher cannabis flower sales in Israel. The improvement in top line was coupled with numerous supply chain efficiencies such as favorable labor and overhead costs as well as lower inventory variances, all culminating to drive a material improvement in gross margin from Q4 20,030. Consolidated adjusted EBITDA in the Q1 was negative $10,700,000 representing a $5,000,000 improvement from the prior year period. The improvement was primarily driven by a decline in general and administrative and research and development expenses and an improvement in gross profit. Following last year's overachievement in savings, we are well on our way to achieving our 2024 goal of saving an incremental $5,000,000 to 10,000,000 dollars In addition to delivering on operational efficiencies and maximizing the return on our cash, we received an interest payment on our GrowCo senior secured loan of approximately $1,400,000 and a principal repayment of approximately $1,200,000 for total cash paid by GrowCo to Cronos of approximately $2,700,000 in Q1. Speaker 300:13:02Having the best balance sheet in the cannabis industry enables us to take calculated strategic bets, while we remain steadfastly focused on reducing cash burn. Turning to the balance sheet, the company ended the quarter with approximately $855,000,000 in cash and cash equivalents. Moving to the cash flow statement, Cash flow from operations was negative approximately $2,200,000 This compares to the negative approximately $47,700,000 in the prior year period, which included a cash outflow of approximately $33,000,000 associated with the Altria warrant relinquishment. And free cash flow, defined as operating cash flow less CapEx, was negative $4,200,000 This compares to a negative approximately $48,500,000 in the prior year period, so a significant improvement. We have many wins to point to this quarter. Speaker 300:13:50Market share gains, OpEx reduction, balance sheet and cash flow optimization, and we are reaffirming our guidance that we anticipate the net change in cash defined as the sum of cash and cash equivalents and short term investments will be positive in 2024. Looking back on the progress we have made, I share in Mike's confidence in the trajectory of our business and our preparedness for entry into new markets as they become available. With that, I'll open the line for questions. Operator00:14:20Thank you. At this time, we will conduct a question and answer session. As a reminder, to ask a question, you will need to press star 11 on your telephone and wait for your name to be announced. Our first question comes from the line of John Zamparo with CIBC. Your line is now open. Speaker 400:15:09I wanted to start on the rescheduling news. And I think I know the answer here, but I want to ask it anyway. Let's say we fast forward to, call it November and we do get a formal rescheduling, everything's been approved. I wonder all other things equal, what does that change for The Cronos Group? Speaker 200:15:29Good morning and thanks, John. I think it's certainly very exciting and a great step in the right direction, but rescheduling is a very broad idea. I think the devil will be in the details. So there'll be a lot of potential opportunities and restrictions. There's a lot of plans that we look at, but I think we really need to see the details before we comment on exactly how we'll pursue a U. Speaker 200:15:53S. Strategy under any potential new framework. Speaker 400:15:58Okay, fair enough. And then moving back to Canada, we've seen softer growth industry wide year to date. That doesn't seem to impact your brands. I wonder what you attribute the industry slowdown to be though, and obviously pricing is a component here. But do you get a sense there's ongoing trade down from consumers? Speaker 400:16:15Because this has always been an extremely price competitive and price sensitive industry. I wonder how the industry can provide more value and how does that influence your strategy? Speaker 200:16:27Sure. So for our brand specifically, we've continued to see growth. And I think what's key is now that we sort of reached a point where you're not seeing significant price compression, at least in flower, it's really bringing new products, bringing superior quality to market and you are competing with an illicit market. So going back to the prepared remarks, I think it's about picking the consumer segments and developing something that's narrowly focused on delivering what their needs are. So that's something that we'll continue to do. Speaker 200:17:03It's something we'll continue to focus on. And you'll see whether Spinach or Lord Jones continuing to develop great products. And I think that's what will drive our growth. Speaker 400:17:15Thank you very much. I'll pass it on. Operator00:17:19Thank you. One moment for our next question. Our next question comes from the line of Matt Bottomley with Canaccord Genuity. Your line is now open. Speaker 500:17:36Good morning, everyone. Thanks for the comments so far. Just wanted to stay in the Canadian market. A lot of us have tracked the retail trends. And as John was mentioning, some of the slowing that we're seeing in the space. Speaker 500:17:46But I'm wondering if you can comment more on what your experience is in the last 3 months or so with respect to the provincial wholesalers. There's been a lot of, especially from some of the leading LPs, a lot of hopeful thinking of and maybe it will come to fruition of the IRS or sorry, I'm in my U. S. Mode, the CRA sort of coming back and really calling some of these old excise tax payables that might lower the amount of saturation in the space. Are you seeing any tangible change with the competitive profile when you're putting purchase orders in from the provinces? Speaker 500:18:16Or do you think that's a longer term trend? Speaker 200:18:20Sure. So I think that the CRA is starting to garnish some of the payments from LPs that aren't paying CRA tax or start paying the excise taxes is a step in the right direction and really does help level the playing field, but certainly I think more action is needed. It's hard to know exactly what's driving some of the trends you see, I'd say, supply starting to dry up. But I think maybe what's bigger than the CRA is likely that you've got reduced supply from all the facility shutdowns you've seen over the last few years. And then also, I think there is increased international demand and that is probably starting to pull some product as well. Speaker 200:19:06So as you can see, we've definitely experienced growth, but I think there's a lot of factors driving that and the CRA would only be one of Speaker 500:19:19them. Okay, understood. And then just another question for me outside of Canada on the international front. Obviously, it's nothing new for any producer to Canada that exports internationally. There's a bulkiness to when product sort of ebbs and flows. Speaker 500:19:33You've had some pretty big swings in Israel and I understand some of the dynamics that are going on there. But is there any forward looking commentary you can give with respect to maybe as 12 month basis forward, what international might look like compared to what it's been historically? Speaker 200:19:53Sure. I want to hold back in giving guidance on percentages. I'll just say that I think Israel will be less lumpy for us because the way that we report Israel versus others because it's a core market for us. We have sales manufacturing in. We're really reporting sell through. Speaker 200:20:12So it's different than say the UK, Australia or Germany. But I will say that we expect significant growth in Germany given the regulatory change and it's a market we're extremely excited about. And I think that U. K. Does have a lot of potential to grow in the back half of the year. Speaker 300:20:33Okay. Operator00:21:24All right. I am showing no further questions at this time. Thank you for your participation in today's conference. This does conclude the program.Read moreRemove AdsPowered by Conference Call Audio Live Call not available Earnings Conference CallLICT Q1 202400:00 / 00:00Speed:1x1.25x1.5x2xRemove Ads Earnings DocumentsInterim report LICT Earnings HeadlinesAs the market dips, I'm eyeing dividend plays like KO and PM – what stocks are on your buy list right now?April 13 at 12:29 PM | 247wallst.comKinder Morgan Insiders Sell US$31m Of Stock, Possibly Signalling CautionApril 13 at 8:35 AM | finance.yahoo.comFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousands of smart, forward-thinking individuals are making the move—out of the system and into real, untouchable assets. Because once your funds are frozen, it’s too late.April 15, 2025 | Priority Gold (Ad)Kinder Morgan, Inc. (NYSE:KMI) Receives $29.64 Average PT from AnalystsApril 13 at 2:31 AM | americanbankingnews.comKinder Morgan (KMI) Stock Moves -1.75%: What You Should KnowApril 10, 2025 | finance.yahoo.comKinder Morgan price target lowered to $25 from $26 at ScotiabankApril 9, 2025 | markets.businessinsider.comSee More Kinder Morgan Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like LICT? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LICT and other key companies, straight to your email. Email Address About LICTLICT (OTCMKTS:LICT), together with its subsidiaries, provides broadband, voice, and video services to residential, commercial, and governmental customers. The company offers high speed broadband services, including internet access through copper-based digital subscriber lines, fiber optic facilities, fixed wireless, and cable modems; video services through traditional cable television services and internet protocol television services; voice over internet protocol services; wireless voice communications services; and other telecommunications related services. It operates in California, Iowa, Kansas, Michigan, New Mexico, Utah, and Wisconsin. The company was formerly known as Lynch Interactive Corporation and changed its name to LICT Corporation in March 2007. LICT Corporation was incorporated in 1996 and is based in Rye, New York.View LICT ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Upcoming Earnings ASML (4/16/2025)CSX (4/16/2025)Abbott Laboratories (4/16/2025)Kinder Morgan (4/16/2025)Prologis (4/16/2025)Travelers Companies (4/16/2025)U.S. Bancorp (4/16/2025)Netflix (4/17/2025)American Express (4/17/2025)Blackstone (4/17/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 6 speakers on the call. Operator00:00:00Good morning. My name is Britney Morgan, and I will be your conference operator today. I would like to welcome everyone to Cronos Group's 2024 First Quarter Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Shane Laidlaw, Investor Relations. Operator00:00:21Please go ahead. Speaker 100:00:23Thank you, Britney, and thank you for joining us today to review Cronos' 2024 Q1 financial and business performance. Today, I am joined by our Chairman, President and CEO, Mike Gorenstein and our CFO, James Holm. Cronos issued a news release announcing our financial results this morning, which is filed on our EDGAR and SEDAR profiles. This information and the prepared remarks will also be posted on our website under Investor Relations. Before I turn the call over to Mike, let me remind you that we may make forward looking statements and refer to non GAAP financial measures during this call. Speaker 100:00:53These forward looking statements are based on management's current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward looking statements. Factors that could cause actual results to differ materially from expectations are detailed in our earnings materials and our SEC filings that are available on our website, by which any forward looking statements made during this call are qualified in their entirety. Information about non GAAP financial measures, including reconciliations to U. S. GAAP can also be found in our earnings materials that are available on our website. Speaker 100:01:23Lastly, we will be making statements regarding market share information throughout this conference call. Unless otherwise stated, all market share data is provided by HiPhire. We will now make prepared remarks and then we'll move to a question and answer session. With that, I'll pass it over to Cronos' Chairman, President and CEO, Mike Gornstein. Speaker 200:01:41Thank you, Shane, and good morning, everyone. Our year is off to a strong start, marked by 30% year over year revenue growth, fueled by market share gains in Canada and a rebound in sales in Israel, gross margin improvement and operating expense reductions from fully realizing the savings we implemented in 2023 as we are well on our way to achieving incremental savings of $5,000,000 $10,000,000 in 2024. The team's consistent and relentless focus on delivering top line growth while simultaneously driving operational efficiency has positioned Cronos for success in 2024 and beyond. I want to take a moment to discuss the cannabis market and our brand possible based on price rather than building a strong connection with the targeted segment of consumers. Without building a strong connection with consumers through a targeted approach, we see many brands we share to more focused offerings. Speaker 200:02:42With spinach, we were very intentional to target specific consumer needs and believe that was instrumental to our success. This strategy drove our success in cementing Spinach as the number 2 brand in Canada. We launched Spinach in Canada at the end of 2018, and since then the team has worked hard to bring thoughtful innovations to market across different categories. I'm so proud of the team and what we've achieved. And we leveraged that success of spinach as a blueprint for our broader portfolio, starting with Lord Jones. Speaker 200:03:10We returned Lord Jones to its adult use roots and brought it to Canada to attack product categories with a more narrow premium focus where we think brand share will be stickier and borderless. Since launching with Hash and Fuse pre rolled in Q4 2023, we expanded the portfolio in Q1 to also include chocolate fusions and live resin vapes that have done well in the early days following the launch. We continue to expand the reach of our leading international brand Peace Naturals. Utilizing our best in class genetics and high quality cultivation, we have brought strains such as wedding cake and GMO cookies to Israel, Germany, Australia and now the UK. Utilizing the Peace Naturals brand in new markets we enter, we continue to cement our flower products as leaders in the market and lay the groundwork for when regulations allow us to launch borderless products such as edibles and vapes. Speaker 200:04:03Let's dive into how our brand is performing in market. Our strength of spinach extends across various product categories, notably in flower, edibles and vapes, where we are top 3 share positions. We've seen exceptional performance with our top products such as our GMO cookies flower, sours by spinach edibles and new flavor forward 1.2 gram base, driving significant market traction. In Q1, Spinach continued its strength in the dried flower category, remaining the number one brand with 6.5% of retail sales. This success is driven by years of genetic breeding, investment in R and D, including tissue culture and best in class cultivation at scale with our JV Cronos GrowCo. Speaker 200:04:49In the quarter, we launched new flower strains and formats, including ASG in 28 grams and Alien Kush in 3.5 grams, and we continue to develop new strains to bring to market, which capitalize on this lead. We also launched a new brand specifically for the Quebec market called Sonique, which will feature high quality flower products to meet consumer demand for this market. In the edibles category, spinach had 14.4% market share in Q1. Our focus on developing innovative strategies and products in this category have been instrumental in this success. The key addition to our product lineup is the fully blasted sours, a high potency 1 pack 10 milligram THC gummy, which garnered early momentum in Q1, and we are encouraged by early sales to date. Speaker 200:05:35With non compliant edibles coming off the market again and the introduction of our competitive 1 pack 10 milligram dummy, we are confident we are bringing the right products to market. Beyond our Spinach brand, we launched Lord Jones Chocolate Fusions, a bite sized chocolate featuring a dynamic multi textured experience. We believe our chocolate fusions will be a category defining product and are looking forward to getting it into more retail locations over the coming months. In the vape category, spinach maintained our number 3 market position, but gained share sequentially, now capturing 7.6% of retail sales in the category. Our new and improved spinach 1.2 gram base have received positive feedback, further solidifying our market presence and growth in this category. Speaker 200:06:22We also launched 2 new spinach all in one vapes, Pineapple Paradise and Blueberry Dynamite. Under the Lord Jones umbrella, we launched Lord Jones Live Resin Vapes in 2 different hardware options in January. The lineup features versatile sizes, including a half gram trial size in the convenience of a very sleek all in one device and a 1 gram stock up size as a 510 thread cartridge, catering to enthusiasts and those new to the category. We are focused on driving market share in the pre roll category and continue to do extensive product development and R and D work in this area. We've launched several new Flavor 4 infused pre roll offerings under the Spinach brand as well as the multi pack. Speaker 200:07:04The Spinach fully charged party pack is a combination of infused pre rolls at 40% plus THC, which includes the finest cold filtered cannabis extract and the keep coating. Our Hash and Fuse pre roll under the Lord Jones brand has become a fan favorite and my personal favorite product. Our continued focus is to be leaders in all categories we operate in and that remains a north star for our efforts in the pre roll category. Turning our attention to international markets. Our operations in Israel rebounded well from Q4, which was impacted by the war. Speaker 200:07:39And Q1 was the highest revenue quarter in Israel since Q4 of 2022. The team in Israel has done a ton of work to refine their processes and approach to the market, which has yielded both higher volumes and improved average selling prices sequentially. Our strength in Israel is also driven by our GMO and wedding cake genetics, which were developed in house and have propelled the Peace Naturals brand to be a leader in the market it enters. In April, we appointed Adam Wagner as SVP, Head of Product Israel, where he was previously the VP of Finance. Adam brings significant finance and operational experience across both public and private companies to this leadership position. Speaker 200:08:21We are already seeing a positive impact from his leadership and look forward to his leadership of the business. We are confident that our team's approach to the Israeli market is as good as ever, and I believe that with their leadership, we will continue to refine and improve over time. We're particularly excited about our growth potential in Germany, where recent legislative changes have fueled material incremental growth in the market and have allowed for opportunities to responsibly market medical cannabis products, which was not permitted under previous regulations. We are committed to delivering high quality cannabis products and nurturing our relationship with our partner, Canisotiva. We're also excited to announce another international milestone earlier this week with our first shipment to the U. Speaker 200:09:04K. Medical market. We intend to establish our Peace Naturals brand as the top medical brand for patients in the UK as we've done in Israel and Germany. International revenue can be lumpy from quarter to quarter. So although we did not have revenue in Q1 in Germany or Australia following our initial load in, we are very pleased with the end market sell through in the quarter. Speaker 200:09:27We are confident about the trajectory of our international revenue in 2024, underscoring our commitment to global expansion and revenue diversification. Our joint venture, Groco, continues to excel, demonstrating robust performance in line with our expectations. Groco reported to us preliminary unaudited revenue of approximately $5,100,000 from non Cronos customers in the Q1. Additionally, the credit facility that Cronos previously provided BroCo currently has $67,100,000 outstanding, following the principal repayments of $1,200,000 in Q1. In addition, Groco made interest payments of $1,400,000 in Q1. Speaker 200:10:08The solid financial performance of GroCo yielding equity pickup, interest payments and the loan payback to Cronos is a vital component of our overall financial picture. Turning to the U. S, last week, the media reported that the DEA plans to follow the HHS' recommendation to reschedule cannabis to Schedule 3. Proposal, which still needs to be reviewed by the White House Office of Management and Budget, would not legalize cannabis federally for adult use, but it's a dramatic shift in how the plant will be classified. We think incremental progress is great for the industry and this is a step in the right direction. Speaker 200:10:45This quarter's successes have resulted from our steadfast focus on building a portfolio of borderless products with strategic infrastructure and global partnerships. Our long term strategy to invest in branded innovation that targets specific consumer needs or remaining asset light is working and we're off to a tremendous start for our 2024 fiscal year. The combination of these efforts and an industry leading balance sheet sets us up well to grow in our current market and execute any new market we decide to enter. With that, I'd like to pass it on to James to take you through our financials. Speaker 300:11:17Thanks, Mike. Good morning, everyone. I will now review our Q1 2024 results in relation to the prior year period. The company reported consolidated net revenue of $25,300,000 a 30% increase from the prior year period. Constant currency consolidated net revenue increased by 31 percent to $25,500,000 The revenue increase was primarily driven by higher cannabis flower extract sales in Canada and higher cannabis flower sales in Israel. Speaker 300:11:45Gross profit in the Q1 was $4,500,000 equating to an 18% gross margin representing a $1,500,000 improvement in gross profit and a 2 70 basis point improvement in gross margin from the prior year The increase is primarily driven by higher sales in cannabis flower extracts in Canada and higher cannabis flower sales in Israel. The improvement in top line was coupled with numerous supply chain efficiencies such as favorable labor and overhead costs as well as lower inventory variances, all culminating to drive a material improvement in gross margin from Q4 20,030. Consolidated adjusted EBITDA in the Q1 was negative $10,700,000 representing a $5,000,000 improvement from the prior year period. The improvement was primarily driven by a decline in general and administrative and research and development expenses and an improvement in gross profit. Following last year's overachievement in savings, we are well on our way to achieving our 2024 goal of saving an incremental $5,000,000 to 10,000,000 dollars In addition to delivering on operational efficiencies and maximizing the return on our cash, we received an interest payment on our GrowCo senior secured loan of approximately $1,400,000 and a principal repayment of approximately $1,200,000 for total cash paid by GrowCo to Cronos of approximately $2,700,000 in Q1. Speaker 300:13:02Having the best balance sheet in the cannabis industry enables us to take calculated strategic bets, while we remain steadfastly focused on reducing cash burn. Turning to the balance sheet, the company ended the quarter with approximately $855,000,000 in cash and cash equivalents. Moving to the cash flow statement, Cash flow from operations was negative approximately $2,200,000 This compares to the negative approximately $47,700,000 in the prior year period, which included a cash outflow of approximately $33,000,000 associated with the Altria warrant relinquishment. And free cash flow, defined as operating cash flow less CapEx, was negative $4,200,000 This compares to a negative approximately $48,500,000 in the prior year period, so a significant improvement. We have many wins to point to this quarter. Speaker 300:13:50Market share gains, OpEx reduction, balance sheet and cash flow optimization, and we are reaffirming our guidance that we anticipate the net change in cash defined as the sum of cash and cash equivalents and short term investments will be positive in 2024. Looking back on the progress we have made, I share in Mike's confidence in the trajectory of our business and our preparedness for entry into new markets as they become available. With that, I'll open the line for questions. Operator00:14:20Thank you. At this time, we will conduct a question and answer session. As a reminder, to ask a question, you will need to press star 11 on your telephone and wait for your name to be announced. Our first question comes from the line of John Zamparo with CIBC. Your line is now open. Speaker 400:15:09I wanted to start on the rescheduling news. And I think I know the answer here, but I want to ask it anyway. Let's say we fast forward to, call it November and we do get a formal rescheduling, everything's been approved. I wonder all other things equal, what does that change for The Cronos Group? Speaker 200:15:29Good morning and thanks, John. I think it's certainly very exciting and a great step in the right direction, but rescheduling is a very broad idea. I think the devil will be in the details. So there'll be a lot of potential opportunities and restrictions. There's a lot of plans that we look at, but I think we really need to see the details before we comment on exactly how we'll pursue a U. Speaker 200:15:53S. Strategy under any potential new framework. Speaker 400:15:58Okay, fair enough. And then moving back to Canada, we've seen softer growth industry wide year to date. That doesn't seem to impact your brands. I wonder what you attribute the industry slowdown to be though, and obviously pricing is a component here. But do you get a sense there's ongoing trade down from consumers? Speaker 400:16:15Because this has always been an extremely price competitive and price sensitive industry. I wonder how the industry can provide more value and how does that influence your strategy? Speaker 200:16:27Sure. So for our brand specifically, we've continued to see growth. And I think what's key is now that we sort of reached a point where you're not seeing significant price compression, at least in flower, it's really bringing new products, bringing superior quality to market and you are competing with an illicit market. So going back to the prepared remarks, I think it's about picking the consumer segments and developing something that's narrowly focused on delivering what their needs are. So that's something that we'll continue to do. Speaker 200:17:03It's something we'll continue to focus on. And you'll see whether Spinach or Lord Jones continuing to develop great products. And I think that's what will drive our growth. Speaker 400:17:15Thank you very much. I'll pass it on. Operator00:17:19Thank you. One moment for our next question. Our next question comes from the line of Matt Bottomley with Canaccord Genuity. Your line is now open. Speaker 500:17:36Good morning, everyone. Thanks for the comments so far. Just wanted to stay in the Canadian market. A lot of us have tracked the retail trends. And as John was mentioning, some of the slowing that we're seeing in the space. Speaker 500:17:46But I'm wondering if you can comment more on what your experience is in the last 3 months or so with respect to the provincial wholesalers. There's been a lot of, especially from some of the leading LPs, a lot of hopeful thinking of and maybe it will come to fruition of the IRS or sorry, I'm in my U. S. Mode, the CRA sort of coming back and really calling some of these old excise tax payables that might lower the amount of saturation in the space. Are you seeing any tangible change with the competitive profile when you're putting purchase orders in from the provinces? Speaker 500:18:16Or do you think that's a longer term trend? Speaker 200:18:20Sure. So I think that the CRA is starting to garnish some of the payments from LPs that aren't paying CRA tax or start paying the excise taxes is a step in the right direction and really does help level the playing field, but certainly I think more action is needed. It's hard to know exactly what's driving some of the trends you see, I'd say, supply starting to dry up. But I think maybe what's bigger than the CRA is likely that you've got reduced supply from all the facility shutdowns you've seen over the last few years. And then also, I think there is increased international demand and that is probably starting to pull some product as well. Speaker 200:19:06So as you can see, we've definitely experienced growth, but I think there's a lot of factors driving that and the CRA would only be one of Speaker 500:19:19them. Okay, understood. And then just another question for me outside of Canada on the international front. Obviously, it's nothing new for any producer to Canada that exports internationally. There's a bulkiness to when product sort of ebbs and flows. Speaker 500:19:33You've had some pretty big swings in Israel and I understand some of the dynamics that are going on there. But is there any forward looking commentary you can give with respect to maybe as 12 month basis forward, what international might look like compared to what it's been historically? Speaker 200:19:53Sure. I want to hold back in giving guidance on percentages. I'll just say that I think Israel will be less lumpy for us because the way that we report Israel versus others because it's a core market for us. We have sales manufacturing in. We're really reporting sell through. Speaker 200:20:12So it's different than say the UK, Australia or Germany. But I will say that we expect significant growth in Germany given the regulatory change and it's a market we're extremely excited about. And I think that U. K. Does have a lot of potential to grow in the back half of the year. Speaker 300:20:33Okay. Operator00:21:24All right. I am showing no further questions at this time. Thank you for your participation in today's conference. This does conclude the program.Read moreRemove AdsPowered by